Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€102.00

€102.00

0.000%
-
0.000%
-

-

 
12.12.25 / Stuttgart Stock Exchange WKN: A2AJW7 / Name: NOVANTA / Stock / Machinery, Equipment & Components / Mid Cap /
Your prediction

Novanta Inc Stock

The Novanta Inc price is unchanged compared to yesterday.
Our community identified positive and negative aspects for Novanta Inc stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Novanta Inc stock. On the other hand our users think that "General Risks" could be a problem in the future.

Pros and Cons of Novanta Inc in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
B****
Cons
?
G***** c******* t* c**********
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Novanta Inc vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Novanta Inc 0.000% 3.553% 10.870% -35.849% -30.612% -27.143% 5.155%
Hubbell Inc. 1.590% 2.128% -2.041% -11.927% -4.478% - -
ITT Corp 2.070% -4.516% -9.202% 2.069% 9.630% 90.968% 133.071%
John Bean Technologies Corp. 4.100% 6.723% 3.252% 7.627% 2.419% 49.412% 25.743%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-05-14

Upon initial examination of the financial statements of NOVANTA, from the Machinery, Equipment & Components industry, the company seems to be showcasing a positive financial position in recent years. Total assets, revenues, and net income have all experienced growth, with the balance sheet and cash flow statements reflecting a robust financial framework. However, an in-depth analysis of the financial documents presents intriguing insights into the company's strengths, weaknesses, and growth opportunities.

Growing Total Assets: From 2020 to 2022, NOVANTA experienced a steady increase in their total assets, with the figures rising from $865,179,000 to $1,241,212,000. This increase signals the firm's ability to expand its financial resources and invest in new opportunities.

Rising Net Income: The company's net income has seen a consistent growth trajectory from 2020 to 2022, which reflects the firm's ability to increase its profitability over time. This is a positive sign for investors, as it indicates the company's ability to generate higher returns on investments.

Comments

Prediction Buy
Perf. (%) -5.34%
Target price 162.500
Change
Ends at 08.03.26

Hey there! I've been keeping an eye on Novanta Inc., and I've got to say, it's caught my attention. Sure, their 2024 results were a bit of a rollercoaster, but here's the thing – this company's got some serious potential. They're all about precision tech in healthcare, which is a field that's only going to grow. Yeah, they hit a few bumps with delayed orders and global economic hiccups, but who hasn't these days? The fact that they're still projecting high single-digit growth for 2025 is pretty impressive. It's like they've hit a speed bump but are revving up for a smooth ride ahead. Their focus on advanced photonics and precision motion tech feels like they're surfing the wave of future healthcare needs. Plus, with the stock price around $132 now, it seems like there's room for growth. It's not without risks, but if you ask me, Novanta could be a hidden gem in the making. Just imagine it as a high-tech surfboard – it might take some skill to ride, but the potential payoff could be totally gnarly!
Show more